Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,474.00GBp
22 Sep 2017
Change (% chg)

6.00 (+0.41%)
Prev Close
1,468.00
Open
1,462.50
Day's High
1,483.00
Day's Low
1,460.50
Volume
6,466,859
Avg. Vol
8,813,242
52-wk High
1,745.56
52-wk Low
1,444.00

Elsenhans, Lynn 

Ms. Lynn Laverty Elsenhans is Non-Executive Independent Director of GlaxoSmithKline Plc., since 1 July 2012. She has a wealth of experience of running a global business and significant knowledge of the global markets in which GSK operates. She served as Chair, President and Chief Executive Officer of Sunoco Inc. from 2009 to 2012. Prior to joining Sunoco in 2008 as President and Chief Executive Officer, Lynn worked for Royal Dutch Shell which she joined in 1980 and where she held a number of senior roles, including Executive Vice President, Global Manufacturing from 2005 to 2008. External appointments Lynn is a Non-Executive Director of Baker Hughes Inc. and Flowserve Corporation, a Director of the Texas Medical Center, and a Non-Executive Director of The First Tee of Greater Houston. She is also a Trustee of the United Way of Greater Houston.

Basic Compensation

Total Annual Compensation, GBP 136,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 63,000
Fiscal Year Total, GBP 199,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --